JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, J. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wilson, J. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 144, Issue 3, 429-436, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


TERATOGENIC INTERACTION OF CHEMICAL AGENTS IN THE RAT

James G. Wilson 1

1 Department of Anatomy, University of Florida College of Medicine, Gainesville, Florida

Six known teratogens, trypan blue, hypervitaminosis A, cyclophosphamide, 6-mercaptopurine, 5-fluorouracil and actinomycin D, have been administered in pairs at low dosage levels to female rats on the 8th or 9th days of pregnancy. Gestation was terminated on the 20th day and the conceptuses examined for intrauterine death and for malformations.

All pairs of agents tested showed appreciable potentiation of teratogenic effect, even when very small doses were used, provided the dosage was above an arbitrary threshold level. No such consistent pattern of interaction was observed as regards intrauterine death.

In several instances significant potentiation occurred when one of two agents was used at subthreshold and the other at low suprathreshold level.

In two instances, namely, actinomycin D with 5-fluorouracil and actinomycin D with cyclophosphamide, potentiation was observed when both agents were used at subthreshold or barely threshold levels. When these three agents were employed simultaneously at threshold and sub-threshold levels a still higher degree of potentiation resulted.

It is thus established that chemical teratogenic agents can be used in certain combinations at low, even subthreshold dosages, to produce malformations at a rate considerably above the rate expected when only one agent is used alone. This may serve as a model for explaining some of the presently unaccounted for human malformation.

Submitted on December 16, 1963
Accepted on January 13, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.